UniProtKB/SwissProt variant VAR

Variant information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Cysteine (C) to Tyrosine (Y) at position 134 (C134Y, p.Cys134Tyr).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and polar (C) to large size and aromatic (Y)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In HEMB.

Any additional useful information about the variant.

Sequence information

Variant position:

134

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

461

The length of the canonical sequence.

Location on the sequence:

SYECWCPFGFEGKNCELDVT C NIKNGRCEQFCKNSADNKVV

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSADNKVV

                              SYECWCRAGFEGKNCELDVTCNIKNGRCKQFCKLGPDNKVV

Chimpanzee                    SYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSADNKVV

Mouse                         SYECWCQVGFEGRNCELDATCNIKNGRCKQFCKNSPDNKVI

Rat                           SYECWCQAGFEGRNCELDATCSIKNGRCKQFCKNSPDNKII

Bovine                        SYECWCQAGFEGTNCELDATCSIKNGRCKQFCKRDTDNKVV

Cat                           SYECWCQTGFEGKNCELDVTCNIKNGRCKQFCKLDADNKVV

Chicken                       SYECMCPPGYGGRNCEIDSTCATKNGGCEHFCRHDTPQKAV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	47 – 461	Coagulation factor IX
Chain	47 – 191	Coagulation factor IXa light chain
Domain	130 – 171	EGF-like 2
Modified residue	114 – 114	Phosphoserine
Disulfide bond	134 – 145
Turn	134 – 136

Literature citations

Molecular pathology of haemophilia B in Turkish patients: identification of a large deletion and 33 independent point mutations.
Onay U.V.; Kavakli K.; Kilinc Y.; Gurgey A.; Aktuglu G.; Kemahli S.; Ozbek U.; Caglayan S.H.;
Br. J. Haematol. 120:656-659(2003)
Cited for: VARIANTS HEMB TYR-28; LEU-43; GLN-43; SER-52; ASP-106; LYS-124; TYR-134; GLN-226; GLY-226; TRP-226; LYS-241; TYR-252; GLN-294; PHE-316; ARG-318; GLY-379; ILE-383; PHE-383; ILE-395; PHE-396; ARG-407 AND GLU-412;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00740: Variant p.Cys134Tyr